CERo Therapeutics Holdings Inc (NASDAQ: CERO) Now -99.46% Off Its High ($12.80), Does Analysts See Headwinds And Risks?

CERo Therapeutics Holdings Inc (NASDAQ:CERO) currently has a daily average trading volume of 66.64M but it saw 17399224 shares traded in last market. With a market cap of 10.46M USD, the company’s current market price of $0.07 came falling about -8.42 while comparing to the previous closing price of $0.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.80 and as low as $0.06. In the recent trading on the day, stock has struck highest price mark of $0.0681 while lowest mark touched by it was $0.078.

Taking a look at 20-day trading activity of CERo Therapeutics Holdings Inc (CERO) gives us an average price of $0.1788, while its current price level is -99.46% below from 52-week high level whereas it is 9.43% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1315 while that of 200 days or SMA-200 reads an average of $0.7090. A closer look into the stock’s movement over the week reveals that its volatility is standing at 27.40% during that period while stretching the period over a month that decreases to 26.71%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 36.69 which implies that the stock is in neutral territory.

Over the week, CERO’s stock price is moving -63.66% down while it is -73.99% when we observe its performance for the past one month. Year-to-date it is -99.37% down and over the past year, the stock is showing a downside performance of -99.36%.

The company is expected to be releasing its next quarterly report in January, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, CERo Therapeutics Holdings Inc’s total number of outstanding shares is 147.54M. Company’s return on equity (ROE) at -4090.08%. Stock’s beta reads 0.29. Its return on asset (ROA) is -108.70% on average.